Berardinelli-Seip Syndrome

Berardinelli-Seip syndrome (BSS), also known as congenital generalized lipodystrophy (CGL), is a rare genetic disorder that affects the body’s ability to produce and store fat. The condition is inherited in an autosomal recessive manner, meaning that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.

BSS is characterized by a near-complete absence of adipose tissue (body fat), which results in a number of metabolic abnormalities and complications. There are four main subtypes of BSS, each with its own distinct genetic cause and clinical presentation. These subtypes are based on the gene involved in the disorder:

  1. Type 1 BSS: This subtype is caused by mutations in the AGPAT2 gene, which encodes an enzyme called 1-acylglycerol-3-phosphate-O-acyltransferase 2. This enzyme is involved in the synthesis of triglycerides, which are the main form of fat storage in the body. Individuals with type 1 BSS typically have a complete absence of adipose tissue and suffer from insulin resistance, diabetes, and an enlarged liver and spleen.
  2. Type 2 BSS: This subtype is caused by mutations in the BSCL2 gene, which encodes a protein called seipin. Seipin is thought to be involved in the formation and maintenance of adipose tissue. Individuals with type 2 BSS typically have a near-complete absence of adipose tissue, insulin resistance, diabetes, and an enlarged liver and spleen. They may also have muscle weakness and abnormal bone development.
  3. Type 3 BSS: This subtype is caused by mutations in the CAV1 gene, which encodes a protein called caveolin-1. Caveolin-1 is involved in the formation and function of caveolae, which are small invaginations in the cell membrane. Individuals with type 3 BSS typically have a partial absence of adipose tissue, insulin resistance, diabetes, and an enlarged liver and spleen. They may also have lung and bone abnormalities.
  4. Type 4 BSS: This subtype is caused by mutations in the PTRF gene, which encodes a protein called polymerase I and transcript release factor. PTRF is involved in the formation and function of caveolae, similar to caveolin-1. Individuals with type 4 BSS typically have a partial absence of adipose tissue, insulin resistance, diabetes, and an enlarged liver and spleen. They may also have muscle weakness and abnormal bone development.

Causes

There are known causes of Berardinelli-Seip syndrome, which can be broadly categorized into three groups:

  1. Autosomal dominant mutations in the LMNA gene: This is the most common cause of Berardinelli-Seip syndrome and accounts for about 50% of cases. The LMNA gene provides instructions for making a protein called lamin A, which is involved in maintaining the structural integrity of cells. Mutations in this gene can cause a variety of health problems, including Berardinelli-Seip syndrome.
  2. Autosomal recessive mutations in the AGPAT2, BSCL2, or CAV1 genes: These mutations account for approximately 25% of cases of Berardinelli-Seip syndrome. The AGPAT2 gene provides instructions for making an enzyme called acylglycerol-3-phosphate O-acyltransferase 2, which is involved in the synthesis of fat. The BSCL2 gene provides instructions for making a protein called seipin, which is involved in the formation and storage of fat. The CAV1 gene provides instructions for making a protein called caveolin 1, which is involved in the formation of small lipid rafts within cells.
  3. Unknown cause: In approximately 25% of cases, the cause of Berardinelli-Seip syndrome is unknown.
  4. AGPAT2 mutations: The most common cause of Berardinelli-Seip syndrome is mutations in the AGPAT2 gene. This gene provides instructions for making a protein involved in the formation of fat cells. Mutations in this gene can cause the formation of too few or abnormal fat cells, leading to a near complete absence of body fat.
  5. BSCL2 mutations: Another common cause of Berardinelli-Seip syndrome is mutations in the BSCL2 gene. This gene provides instructions for making a protein involved in the transport and storage of fats in cells. Mutations in this gene can lead to the abnormal storage of fats in cells, leading to a near complete absence of body fat.
  6. CAV1 mutations: Mutations in the CAV1 gene can also cause Berardinelli-Seip syndrome. This gene provides instructions for making a protein that helps regulate the formation of blood vessels. Mutations in this gene can lead to abnormal blood vessel formation and fat distribution in the body.
  7. PTRF mutations: Mutations in the PTRF gene can also cause Berardinelli-Seip syndrome. This gene provides instructions for making a protein involved in the formation and maintenance of fat cells. Mutations in this gene can cause the formation of too few or abnormal fat cells, leading to a near complete absence of body fat.
  8. Familial partial lipodystrophy: Berardinelli-Seip syndrome can also be caused by familial partial lipodystrophy, which is an inherited form of the condition that is passed down from parents to children. This form of the condition is characterized by a partial loss of body fat, rather than a near complete loss.
  9. Acquired partial lipodystrophy: Berardinelli-Seip syndrome can also be caused by acquired partial lipodystrophy, which is a form of the condition that is not inherited but develops over time due to other underlying medical conditions or medications.
  10. Autoimmune disorders: Certain autoimmune disorders, such as lupus and rheumatoid arthritis, can lead to the loss of body fat and the development of Berardinelli-Seip syndrome.
  11. HIV/AIDS: HIV/AIDS can also cause the loss of body fat and the development of Berardinelli-Seip syndrome. This is because the virus attacks and destroys the cells responsible for producing and storing fat.
  12. Medications: Certain medications, such as antiretroviral drugs used to treat HIV/AIDS, can also cause the loss of body fat and the development of Berardinelli-Seip syndrome.
  13. Tumors: Tumors can also cause the loss of body fat and the development of Berardinelli-Seip syndrome. This is because tumors can interfere with the normal functioning of the cells responsible for producing and storing fat.
  14. Liver disease: Certain liver diseases, such as hepatitis and cirrhosis, can also cause the loss of body fat and the development of Berardinelli-Seip syndrome. This is because the liver is responsible for producing and storing fats

Symptoms

Common symptoms associated with this disorder:

  1. Extreme thinness: One of the most distinctive features of Berardinelli-Seip syndrome is a lack of body fat, which leads to extreme thinness and gaunt appearance.
  2. Muscle wasting: The lack of body fat in Berardinelli-Seip syndrome can also cause muscle wasting and weakness, which can lead to difficulty with everyday activities.
  3. Hypertriglyceridemia: High levels of triglycerides, a type of fat found in the blood, are a hallmark of Berardinelli-Seip syndrome and can lead to severe and potentially life-threatening pancreatitis.
  4. Hyperinsulinemia: High levels of insulin, the hormone that regulates blood sugar levels, are also common in Berardinelli-Seip syndrome and can lead to insulin resistance and type 2 diabetes.
  5. Acanthosis nigricans: This is a skin condition characterized by dark, thick, velvety patches on the skin, particularly in the folds of the neck, groin, and armpits.
  6. Liver steatosis: Fatty infiltration of the liver, also known as liver steatosis, is a common complication of Berardinelli-Seip syndrome and can lead to liver damage and dysfunction.
  7. Hyperandrogenism: High levels of androgens, male sex hormones, are seen in some individuals with Berardinelli-Seip syndrome and can lead to virilization, hirsutism, and other symptoms of excessive male hormone production.
  8. Cardiac hypertrophy: Enlargement of the heart, also known as cardiac hypertrophy, is a common finding in Berardinelli-Seip syndrome and can lead to heart failure and other cardiovascular complications.
  9. Lipoatrophy: A condition characterized by localized loss of body fat, particularly in the face, legs, and arms.
  10. Pancreatitis: Inflammation of the pancreas, which can lead to severe abdominal pain and potentially life-threatening complications.
  11. Hyperlipidemia: High levels of lipids, such as cholesterol and triglycerides, in the blood, which can lead to an increased risk of heart disease and stroke.
  12. Hypertension: High blood pressure, which can lead to an increased risk of heart disease and stroke.
  13. Hyperuricemia: High levels of uric acid in the blood, which can lead to gout and kidney damage.
  14. Insulin resistance: Decreased sensitivity to insulin, the hormone that regulates blood sugar levels, which can lead to type 2 diabetes and other metabolic complications.
  15. Sleep apnea: A condition characterized by repeated pauses in breathing during sleep, which can lead to excessive daytime sleepiness and other symptoms.
  16. Carpal tunnel syndrome: A condition characterized by numbness, tingling, and weakness in the hands and arms, which can be caused by compression of the median nerve in the wrist.
  17. Fatty liver disease: A condition characterized by the accumulation of fat in the liver, which can lead to liver damage and dysfunction.
  18. Infertility: A lack of body fat in Berardinelli-Seip syndrome can lead to infertility in both men and women.
  19. Depression and anxiety: The physical and metabolic abnormalities associated with Berardinelli-Seip syndrome

Diagnosis

Diagnostic tests that can be used to diagnose Berardinelli-Seip syndrome.

  1. Physical examination: A thorough physical examination is the first step in the diagnostic process. A physician will look for signs of lipoatrophy, including a sunken face, thin arms and legs, and a protruding abdomen. The absence of subcutaneous fat can be confirmed by pinching the skin and observing if there is a lack of tissue between the fingers.
  2. Blood tests: Blood tests are used to assess the levels of glucose, insulin, triglycerides, and other lipids in the blood. Elevated levels of glucose, insulin, and triglycerides are common in Berardinelli-Seip syndrome and can help confirm the diagnosis.
  3. Genetic testing: Genetic testing is a crucial tool in the diagnosis of Berardinelli-Seip syndrome. A blood test can be done to identify mutations in the genes associated with the condition, including AGPAT2, BSCL2, and CAV1.
  4. Biopsy: A biopsy of the affected area can be performed to confirm the absence of adipose tissue. The biopsy sample is analyzed under a microscope to confirm the absence of fat cells.
  5. Magnetic Resonance Imaging (MRI): MRI is used to assess the distribution and amount of fat in the body. An MRI can help identify areas of the body where fat is absent or reduced, which is characteristic of Berardinelli-Seip syndrome.
  6. Computed Tomography (CT) scan: A CT scan is a type of X-ray that provides detailed images of the body’s internal structures. A CT scan can be used to confirm the absence of fat in the body and identify any associated liver or pancreas abnormalities.
  7. Positron Emission Tomography (PET) scan: A PET scan is a type of nuclear medicine imaging test that uses a small amount of radioactive material to produce detailed images of the body’s internal structures. A PET scan can be used to assess the distribution and amount of fat in the body and help confirm the diagnosis of Berardinelli-Seip syndrome.
  8. Ultrasound: An ultrasound is a non-invasive test that uses high-frequency sound waves to produce images of the body’s internal structures. An ultrasound can be used to assess the distribution and amount of fat in the body and help confirm the diagnosis of Berardinelli-Seip syndrome.
  9. Dual-energy X-ray absorptiometry (DXA): DXA is a type of X-ray that measures the density of bones. A DXA scan can be used to assess the amount of fat in the body and help confirm the diagnosis of Berardinelli-Seip syndrome.
  10. Hormonal testing: Hormonal testing is used to assess the levels of hormones such as leptin, adiponectin, and growth hormone in the blood. Low levels of these hormones are common in Berardinelli-Seip syndrome and can help confirm the diagnosis.

Treatment

There is currently no cure for Berardinelli–Seip syndrome, but there are a number of treatments available to help manage its symptoms and reduce the risk of associated health problems. Here is a list of treatment options for Berardinelli–Seip syndrome:

  1. Insulin therapy: Insulin resistance is a common problem in Berardinelli–Seip syndrome and many people with this condition will require insulin therapy to manage their blood sugar levels.
  2. Metformin: Metformin is a medication commonly used to treat type 2 diabetes. It can help improve insulin sensitivity and reduce the risk of developing diabetes in people with Berardinelli–Seip syndrome.
  3. Thiazolidinediones: Thiazolidinediones, also known as TZDs, are a class of medications that can help improve insulin sensitivity. They are often used in combination with insulin therapy to manage blood sugar levels in people with Berardinelli–Seip syndrome.
  4. Statins: Statins are medications that can help lower cholesterol levels and reduce the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  5. Niacin: Niacin is a type of B vitamin that can help lower triglyceride levels in people with Berardinelli–Seip syndrome.
  6. Fibrates: Fibrates are medications that can help lower triglyceride levels and improve cholesterol levels in people with Berardinelli–Seip syndrome.
  7. Omega-3 fatty acids: Omega-3 fatty acids are a type of polyunsaturated fat that can help reduce the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  8. Antioxidants: Antioxidants, such as vitamin E and selenium, can help protect against oxidative stress and reduce the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  9. Vitamin D supplementation: Vitamin D is important for bone health, and people with Berardinelli–Seip syndrome may require supplementation to maintain adequate levels.
  10. Calcium supplementation: Calcium is important for bone health, and people with Berardinelli–Seip syndrome may require supplementation to maintain adequate levels.
  11. Physical activity: Regular physical activity can help improve insulin sensitivity and reduce the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  12. Weight management: Maintaining a healthy body weight is important for managing insulin resistance and reducing the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  13. Healthy diet: A diet that is low in refined carbohydrates and high in fiber, healthy fats, and protein can help improve insulin sensitivity and reduce the risk of cardiovascular disease in people with Berardinelli–Seip syndrome.
  14. Smoking cessation: Smoking increases the risk of cardiovascular disease in people with Berardinelli–Seip syndrome, and quitting smoking can help reduce this risk.
  15. Stress management: Chronic stress can increase the risk of cardiovascular disease in people with Berardinelli–Seip syndrome, and stress management techniques can help reduce this risk.
  16. Regular health screenings: Regular health screenings, such as lipid panels, glucose tolerance
References